Hemophagocytosis in Critically Ill Adult Patients

Recruiting now

Conditions studied: Hemophagocytosis

In brief

The purpose of the study is to find out whether non-responsiveness to therapeutic recombinant human granulocyte colony-stimulation factor (rhG-CSF) is associated with hemophagocytosis in critically ill adult patients with cytopenias.

Key facts

Study ID

NCT01913938

Run by

University of Ulm

People needed

40

Starts

2013-07-01

Expected to finish

2026-12-01

Last updated by the study team

2024-01-17

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age > 18 years
• critically ill adult patients
• leukopenia and thrombocytopenia
• rhG-CSF therapy

You may not qualify if…

• life expectancy < 24 hours
• inclusion in other studies
• trauma patients with reanimation on scene or immediately dying on hospital admission
• pregnancy
• hematologic disorder, malignancy
• high dose corticosteroid treatment or chemotherapy

Where it is running

• Department of Anaesthesiology, University Hospital Ulm — Ulm, Germany (enrolling)
• Department of Internal Medicine III, Comprehensive Infectious Disease Center, University Hospital Ulm, Germany — Ulm, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.